急性腎障害のためのKDIGO診療ガイドライン

出版社: 東京医学社
著者:
発行日: 2014-01-15
分野: 臨床医学:内科  >  腎臓
ISBN: 9784885632297
電子書籍版: 2014-01-15 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
発送目安:8~14営業日

3,456 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,456 円(税込)

腎臓の構造と機能に影響を与える病態のひとつであるAKI。AKIの定義や予防と治療、造影剤によるAKI、AKI治療のための透析療法などを取り上げる。

目次

  • 表紙
  • 目次
  • KDIGO Board Members
  • レファレンス・キー
  • 略語
  • 告知
  • まえがき
  • Work Group Membership
  • 日本語版全訳ワーキングチーム
  • 日本語全訳版の出版にあたって
  • 要約
  • 推奨サマリー
  • 1章 はじめに
  • 2章 AKIの定義
  • 3章 AKIの予防と治療
  • 4章 造影剤によるAKI ( CI - AKI )
  • 5章 AKI治療のための透析療法
  • Biographic and Disclosure Information
  • Acknowledgements
  • References
  • 索引
  • 奥付

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

References

P.129 掲載の参考文献
4. Levy EM, Viscoli CM, Horwitz Rl. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996 ; 275 : 1489-1494.
18. Bywaters EGL, Beall D. Crush injuries with impairment of renal function. BMJ 1947 ; 1 : 427-432.
21. Liano F, Pascual J. Epidemiology of acute renal failure : a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996 ; 50 : 811-818.
25. Bagshaw SM, George C, Dinu I, et al. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008 ; 23 : 1203-1210.
32. Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Tnt 2007 ; 71 : 1028-1035.
33. Hackworth LA, Wen X, Clermont G, et al. Hospital versus communityacquired acute kidney injury in the critically ill : differences in epidemiology (abstr). J Am Soc Nephrol 2009 ; 20 : 115A.
36. Institute of Medicine. Crossing the Quality Chasm : a New Health System for the 21st Century. National Academy Press : Washington, DC, 2001.
42. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Am J Kidney Dis 2002 ; 39 (2 Suppl 1) : S1-266.
51. Reddy VG. Prevention of postoperative acute renal failure. J Postgrad Med 2002 ; 48 : 64-70.
56. Perez-Valdivieso JR, Bes-Rastrollo M, Monedero P, et al. Prognosis and serum creatinine levels in acute renal failure at the time of nephrology consultation : an observational cohort study. BMC Nephrol 2007 ; 8 : 14.
70. Bellomo R, Wan L, May CN. Vasoactive drugs and acute renal failure. In : Ronco C, Bellomo R, Kellum J (eds). Critical Care Nephrology, 2nd Edn. Saunders Elsevier : Philadelphia, PA, 2009, pp 416-419.
72. Fin fer S, Jones DA. Crystalloids and colloids. In : Ronco C, Bellomo R, Kellum J (eds). Critical Care Nephrology, 2nd Edn. Saunders Elsevier : Philadelphia, PA, 2009, pp 571-575.
73. Holmes CL, Walley KR. Shock. In : Murray PT, Brady HR, Hall JB (eds). Intensive Care in Nephrology. Taylor & Francis : New York, NY, 2006, pp 1-18.
74. Levine JS, Iglesias JI. Diuretic use and fluid management. In : Murray PT, Brady HR, Hall JB (eds). Intensive Care in Nephrology. Taylor & Francis : New York, NY, 2006, pp 315-337.
77. Polanco PM, Pinsky MR. Hemodynamic monitoring in the intensive care unit. In : Ronco C, Bellomo R, Kellum J (eds). Critical Care Nephrology, 2nd Edn. Saunders Elsevier : Philadelphia, PA, 2009, pp 37-45.
79. Schetz M. Assessment of volume status. In : Ronco C, Bellomo R, Kellum J (eds). Critical Care Nephrology, 2nd Edn. Saunders Elsevier : Philadelphia, PA, 2009, pp 499-504.
80. Venkataraman R, Kellum JA. Principles of fluid therapy. In : Ronco C, Bellomo R, Kellum J (eds). Critical Care Nephrology, 2nd Edn. Saunders Elsevier : Philadelphia, PA, 2009, pp 568-571.
90. de Saint-Aurin RG, Kloeckner M, Annane D. Crystalloids versus colloids for fluid resuscitation in critically-ill patients. Acta Clin Belg Suppl 2007 : 412-416.
97. Sakr Y, Payen D, Reinhart K, et al. Effects ofhydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007 ; 98 : 216-224.
106. Redi-Wenzl EM, Armbruster C, Edelmann G, et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993 ; 19 : IS1-IS4.
107. Albanese J, Leone M, Delmas A, et al. Terlipressin or norepinephrine in hyperdynamic septic shock : a prospective, randomized study. Crit Care Med 2005 ; 33 : 1897-1902.
114. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004 ; 32 : 858-873 .
117. Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal proB-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008 ; 29 : 328-333.
119. Lin SM, Huang CD, Lin HC, et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock : a randomized controlled trial. Shock 2006 ; 26 : SS1-SS7.
125. Lobo SM, Salgado PF, Castillo VG, et al. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000 ; 28 : 3396-3404.
128. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. Sv02 Collaborative Group. N Engl J Med 1995 ; 333 : 1025-1032 .
130. Section VII. Acute renal failure. In : Schrier RW (ed). Diseases of the Kidney and Urinary Tract, 8th Edn, vol. 2. Lippincott Williams & Wilkins : Philadelphia, PA, 2007, pp 930-1207.
131. Part VI. Diagnosis and management of specific disorders. In : Jorres A, Ronco C, Kellum JA (eds). Management of Acute Kidney Problems, 1st Edn. Springer : New York, NY, 2010, pp 269-467.
133. Siew ED, Himmelfarb J. Metabolic and nutritional complications of acute kidney injury. In : Himmelfarb J, Sayegh MH (eds). Chronic Kidney Disease, Dialysis, and Transplantation. A Companion to Brenner and Rector's The Kidney, 3rd Edn : London, UK, 2011, pp 654-667.
136. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction : implications for patients with and without recognized diabetes. Circulation 200S ; 111 : 3078-3086.
139. Palevsky PM, Murray PT. Acute kidney injury and critical care nephrology. NephSAP 2006 ; 5 (2) : 72-120.
151. Fiaccadori E, Lombardi M, Leonardi S, et al. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure : a prospective cohort study. J Am Soc Nephrol 1999 ; 10 : S81-S93.
170. Chima CS, Meyer L, Hummell AC, et al. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol 1993 ; 3 : 1516-1521.
174. Barnerl J, Dumitrascu D, Neeser G, et al. Gastric emptying of a liquid meal in intensive care unit patients (abstr). Gastroenterology 1998 ; 114 : A865.
184. Ponto LL, Schoenwald RD. Furosemide (frusemide). A pharmacokinetic/ pharmacodynamic review (Part II). Clin Pharmacokinet 1990 ; 18 : 460-471.
185. Ponto LL, Schoenwald RD. Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I). Clin Pharmacokinet 1990 ; 18 : 381-408.
186. Ludens JH, Hook JB, Brody MJ, et al. Enhancement of renal blood flow by furosemide. J Pharmacal Exp Ther 1968 ; 163 : 456-460.
189. Lassnigg A, Donner E, Grubhofer G, et al. Lack of reno protective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000 ; 11 : 97-104.
194. Hager B, Betschart M, Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr 1996 ; 126 : 666-673.
203. Weimar W, Geerlings W, Bijnen AB, et al. A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation. Transplantation 1983 ; 35 : 99-101.
206. Vanholder R, Sever MS, Erek E, et al. Rhabdomyolysis. J Am Soc Nephrol 2000 ; 11 : 1553-1561.
207. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction : a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000 ; 356 : 2139-2143.
208. Murray PT. Use of dopaminergic agents for renoprotection in the ICU. Yearbook of Intensive Care and Emergency Medicine. Springer-Verlag : Berlin, Germany, 2003 : 637-648.
224. Ricksten SE, Sward K. Atrial natriuretic peptide in acute renal failure. In : Ronco C, Bellomo R, Kellum J (eds). Critical Care Nephrology, 2nd Edn. Saunders Elsevier : Philadelphia, PA, 2009, pp 429-433.
227. Valsson F, Ricks ten SE, Hedner T, et al. Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. J Cardiothorac Vase Anesth 1994 ; 8 : 425-430.
229. Sands JM, Neylan JF, Olson RA, et al. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol 1991 ; 1 : 1081-1086.
231. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997 ; 336 : 828-834.
233. Sward K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure : a randomized placebocontrolled trial. Grit Care Med 2004 ; 32 : 1310-1315.
238. Brenner P, Meyer M, Reichenspurner H, et al. Significance of prophylactic urodilatin (INN : ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation. Eur J Med Res 1995 ; 1 : 137-143.
239. Sackner-Bernstein JO, Kowalski M, Fox M, et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure : a pooled analysis of randomized controlled trials. JAMA 2005 ; 293 : 1900-1905.
240. Sackner-Bernstein JO, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005 ; 111 : 1487-1491.
246. Hammerman MR. Potential role of growth factors in the prophylaxis and treatment of acute renal failure. Kidney Tnt Suppl 1998 ; 64 : S19-22.
249. Friedlaender M, Popovtzer MM, Weiss O, et al. Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure : the effects on renal IGF-1, JGF-1 receptor, and JGF-binding protein-1 mRNA. J Am Soc Nephrol 1995 ; 5 : 1782-1791.
256. Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARI' trial). Kidney Int 2010 ; 77 : 1020-1030.
266. Massie BM, O'Connor CM, Metra M, et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 20 10 ; 363 : 1419-1428.
288. Martinez-Salgado C, Lopez-Hernandez FJ, Lopez-Novoa) M. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacal 2007 ; 223 : 86-98.
304. Peters-Volleberg GW, Dortant PM, Speijers GJ. Comparison of tobramycin nephrotoxicity in young adult and aged female rats. Pharmacal Toxicol 1999 ; 84 : 147-153.
307. Rybak MJ, Abate BJ, Kang SL, et al. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 1999 ; 43 : 1549-1555.
312. Ferriols-Lisart R, Alos-Alminana M. Effectiveness and safety of once-daily aminoglycosides : a meta-analysis. Am J Health Syst Pharm 1996 ; 53 : 1141-1150.
316. LeT, Bayer AS. Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 2003 ; 36 : 615-621.
325. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999 ; 340 : 23-30.
342. Comely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection : a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007 ; 44 : 1289-1297.
343. Garbino J, Adam A. Use of high-dose liposomal amphotericin B : efficacy and tolerance. Acta Biomed 2006 ; 77 (Suppl 4) : 19-22.
344. Girois SB, Chapuis F, Decullier E, et al. Adverse effects of antifungal therapies in invasive fungal infections : review and meta-analysis. Eur J Clin Microbial Infect Dis 2005 ; 24 : 119-130.
356. Schwann NM, Harrow JC, Strong MD, 3rd, et al. Does off-pump coronary artery bypass reduce the incidence of clinicaLly evident renal dysfunction after multivessel myocardial revascularization? Anesth Analg 2004 ; 99 : 959-964, table of contents.
395. Polena S, Yang S, Alam R, et al. Nephropathy in critically Ill patients without preexisting renal disease. Proc West Pharmacal Soc 2005 ; 48 : 134-135.
400. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention : incidence, risk factors, and relationship to mortality. Am J Med 1997 ; 103 : 368-375.
411. Choyke PL, Cady J, DePollar SL, et al. Determination of serum creatinine prior to iodinated contrast media : is it necessary in all patients? Tech Ural 1998 ; 4 : 65-69.
418. Mehran R, Aymong ED, Nikolsky E, et at. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention : development and initial validation. J Am Coli Cardiol 2004 ; 44 : 1393-1399.
437. Laskey WK, Jenkins C, Selzer F, et al. Volume-to-creatinine clearance ratio : a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coli Cardiol 2007 ; 50 : 584-590.
441. Heller CA, Knapp J, Halliday J, et al. Failure to demonstrate contrast nephrotoxicity. Med J Aust 1991 ; 155 : 329-332.
453. Juergens CP, Winter JP, Nguyen-Do P, et al. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving Nacetylcysteine and hydration before coronary angiography and intervention : a randomized trial. Intern Med J 2009 ; 39 : 25-31.
458. Reddan O, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention : What do we really know from evidence-based findings? J Nephrol 2009 ; 22 : 333-351.
459. Jo SH, Youn TJ, Koo BK, et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography : the RECOVER study : a randomized controlled trial. J Am Call Cardiol 2006 ; 48 : 924-930.
468. Stevens MA, McCullough PA, Tobin KJ, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy : results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Call Cardiol 1999 ; 33 : 403-411.
477. Haste EA, De Waele JJ, Gevaert SA, et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury : a systematic review and meta-analysis. Nephrol Dial Transplant 2010 ; 25 : 747-758.
482. Adolph E, Holdt-Lehmann B, Chatterjee T, et al. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE) : a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Caron Artery Dis 2008 ; 19 : 413-419.
488. Recio-Mayoral A, Chaparro M, Prado B, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention : the RENO Study. J Am Colt Cardiol 2007 ; 49 : 1283-1288.
491. Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003 ; 93 : C29-34.
504. Koc F, Ozdemir K, Kaya MG, et al. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy : CASIS-A multicenter prospective controlled trial. Int J Cardiol 2010 : doi : 10.1016/j.ijcard.2010.1010.1041.
505. Arend L J, Bakris GL, Burnett JC, Jr., et al. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987 ; 110 : 406-411.
509. Malhis M, Al-Bitar S, Al-Deen Zaiat K. The role of theophylline in prevention of radiocontrast media-induced nephropathy. Saudi J Kidney Dis Transpl 2010 ; 21 : 276-283.
521. Lee PT, Chou KJ, Liu CP, et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coli Cardia/ 2007 ; 50 : 1015-1020.
526. Allan M, Shanklin N. Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis 1995 ; 26 : 607-613.
533. Fischer RP, Griffen WO, Jr., Reiser M, et al. Early dialysis in the treatment of acute renal failure. Surg Gynecol Obstet 1966 ; 123 : 1019-1023.
550. Mehta RL, McDonald B, Pahl M, et al. Continuous vs. intermittent dialysis for acute renal failure in the ICU : Results from a randomized multicenter trial (abstract). J Am Soc Nephrol 1996 ; 7 : 1456.
552. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005 ; 45 : 96-101.
563. Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008 ; 359 : 7-20.
566. Ho KM, Liang J, Hughes T, et al. Withholding and withdrawal of therapy in patients with acute renal injury : a retrospective cohort study. Anaesth Intensive Care 2003 ; 31 : 509-513.
567. Shealy CB, Campbell RC, Hey JC, et al. 24-hr creatinine clearance as a guide for CRRT withdrawal : a retrospective study (abstr). Blood Purif 2003 ; 21 : 192.
573. Morabito S, Guzzo I, Solazzo A, et al. Continuous renal replacement therapies : anticoagulation in the critically ill at high risk of bleeding. J Nephrol 2003 ; 16 : 566-571.
587. European Best Practice Guidelines for Haemodialysis (Part 1). Y. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system. Nephrol Dial Transplant 2002 ; 17 (Suppl 7) : 63-71.
601. Betjes MG, van Oosterom D, van Agteren M, et al. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding : similar hemofilter survival but significantly less bleeding. J Nephrol 2007 ; 20 : 602-608.
606. Thoenen M, Schmid ER, Binswanger U, et al. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Wien Klin Wochenschr 2002 ; 114 : 108-114.
609. Durao MS, Monte JC, Batista MC, et al. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Crit Care Med 2008 ; 36 : 3024-3029.
612. Meier-Kriesche HU, Gitomer J, Finkel K, et al. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001 ; 29 : 748-752.
615. Holt AW, Bierer P, Bersten AD, et al. Continuous renal replacement therapy in critically ill patients : monitoring circuit function. Anaesth Intensive Care 1996 ; 24 : 423-429.
617. Stefanidis I, Hagel J, Frank D, et al. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure. Clin Nephrol 1996 ; 46 : 199-205.
618. van de Wetering J, Westendorp RG, van der Hoeven JG, et al. Heparin use in continuous renal replacement procedures : the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996 ; 7 : 145-150.
619. Yang RL, Liu OW. [Clinical evaluation of hemofiltration without anti coagulation in critically ill patients at high risk of bleeding]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2007 ; 29 : 651-655.
623. Kozek-Langenecker SA, Spiss CK, Gamsjager T, et al. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration : a randomized controlled trial. Wien Klin Wochenschr 2002 ; 114 : 96-101.
627. Biancofiore G, Esposito M, Bindi L, et al. Regional filter heparinization for continuous vena-venous hemofiltration in liver transplant recipients. Minerva Anestesiol 2003 ; 69 : 527-534 ; 534-528.
628. Kaplan AA, Petrillo R. Regional heparinization for continuous arteriovenous hemofiltration (CAVH). ASATO Trans 1987 ; 33 : 312-315.
629. Carr JA, Silverman N. The heparin-protamine interaction. A review. J Cardiovasc Surg (Torino) 1999 ; 40 : 659-666.
632. O'Shea Sl, Ortel TL, Kovalik EC. Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. Semin Dial 2003 ; 16 : 61-67.
640. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates : vascular access. Am J Kidney Dis 2006 ; 48 : S176-S307.
641. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hasp Epidemiol 2002 ; 23 : 759-769.
642. Leblanc M, Fedak S, Makris G, et al. Blood recirculation in temporary central catheters for acute hemodialysis. Clin Nephrol 1996 ; 45 : 315-319.
646. Ronco C, Dell' Aquila R. Peritoneal access for acute peritoneal dialysis. In : Ronco C, Bellomo R, Kellum J (eds). Critical Care Nephrology, 2nd Edn. Saunders Elsevier : Philadelphia, PA, 2009, pp 1467-1471.
664. Marschall J, Mermel LA, Classen O, et al. Strategies to prevent central lineassociated bloodstream infections in acute care hospitals. Infect Control Hasp Epidemiol 2008 ; 29 (Suppl 1) : S22-30.
670. Karakitsos O, Labropoulos N, De Groot E, et al. Real-time ultrasound-guided catheterisation of the internal jugular vein : a prospective comparison with the landmark technique in critical care patients. Grit Care 2006 ; 10 : R162.
673. Farrell J, Gellens M. Ultrasound-guided cannulation versus the landmarkguided technique for acute haemodialysis access. Nephrol Dial Transplant 1997 ; 12 : 1234-1237.
695. Puentes F, Pons H, Rodriguez-Iturbe B. Hemodialysis with cuprophane membranes is associated with a reduction in peripheral blood mononuclear cells expressing VLA-4 cell adhesion molecule. Clin Nephrol 1994 ; 42 : 278-279.
696. Schaefer RM, Huber L, Gilge U, et al. Clinical evaluation of a new high-flux cellulose acetate membrane. Int J Artif Organs 1989 ; 12 : 85-90.
700. Sirolli V, Strizzi L, Di Stante S, et al. Platelet activation and plateleterythrocyte aggregates in end-stage renal disease patients on hemodialysis. Thromb Haemost 2001 ; 86 : 834-839.
706. Perez-Garcia R, Galan A, Garcia Vinuesa M, et al. Anaphylactoid reactions during hemodialysis on AN69 membranes : role of ACE inhibitors and back-filtration. Nephron 1992 ; 61 : 123.
707. Petrie JJ, Campbell Y, Hawley CM, et al. Anaphylactoid reactions in patients on hemodiafiltration with AN69 membranes whilst receiving ACE inhibitors. Clin Nephrol 1991 ; 36 : 264-265.
710. RENAL Study Investigators. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units : a practice survey. Crit Care Resusc 2008 ; 10 : 225-230.
712. Langford S, Slivar S, Tucker SM, et al. Exploring CRRT practices in ICU : a survey of Canadian hospitals. Dynamics 2008 ; 19 : 18-23.
732. Ronco C, Bellomo R, Brendolan A, et al. Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol 1999 ; 12 : 173-178.
757. Ledebo I. On-line preparation of solutions for dialysis : practical aspects versus safety and regulations. J Am Soc Nephrol 2002 ; 13 (Suppl 1) : S78-83.
759. Ronco C. Backfiltration in clinical dialysis : nature of the phenomenon, mechanisms and possible solutions. Int J Artif Organs 1990 ; 13 : 11-21.
763. Association for the Advancement of Medical Instrumentation. Water for Hemodialysis and Related Therapies. ANST/AAMI/TSO 13959 : 2009. AAMI : Arlington, VA, 2010.
764. Association for the Advancement of Medical Instrumentation. Concentrates for Hemodialysis and Related Therapies. ANST/AAMI/ISO 13958 : 2009. AAMI : Arlington, VA, 2011.
765. Association for the Advancement of Medical Instrumentation. Quality of Dialysis Fluid for Hemodialysis and Related Therapies. ANST/AAMT/TSO 11663 : 2009. AAMI : Arlington, VA, 2010.
769. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous vena-venous haemofiltration on outcomes of acute renal failure : a prospective randomised trial. Lancet 2000 ; 356 : 26-30.
774. Ricci Z, Ronco C, D'Amico G, et al. Practice patterns in the management of acute renal failure in the critically ill patient : an international survey. Nephrol Dial Transplant 2006 ; 21 : 690-696.
780. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996 ; 50 : 550-556.
608 . Apsner R, Schwarzenhofer M, Derfler K, et al. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 1997 ; 109 : 123-127.
765a. European best practice guidelines for haemodialysis (Part 1). Section IV : Dialysis fluid purity. Nephrol Dial Transplant 2002 ; 17 (Suppl) : 45-62.

最近チェックした商品履歴

Loading...